As a participant in the international Global Microbial Identifier (GMI) think tank, RIVM is studying how a new DNA analysis technique can improve the diagnostics of infectious diseases worldwide. ‘If this new technique actually does what is expected , it will be revolutionary. It will allow for all existing viruses to be studied, instead of just those you are familiar with.’

RIVM has ample expertise in scientific research on tobacco and nicotine products control. Since 2001, we conduct independent and objective tobacco research and provide scientific support on tobacco and nicotine products regulation. Our research and policy advice concern the composition and attractive, addicitive and toxic properties of tobacco and nicotine products, and their impact on human health, with a focus on (flavouring) ingredients.